日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I

USP22 通过 EZH2 介导的 MHC-I 表观遗传沉默驱动肿瘤免疫逃逸和免疫检查点阻断耐药。

Liu, Kun; Iyer, Radhika; Li, Yi; Zhu, Jun; Cai, Zhaomeng; Wei, Juncheng; Cheng, Yang; Tang, Amy Y; Wang, Hai; Gao, Qiong; Mani, Nikita Lavanya; Marx, Noah; Gao, Beixue; Watterson, D Martin; Khan, Seema A; Gradishar, William J; Liu, Huiping; Fang, Deyu

Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

确定 p38 MAPK 抑制作为 SMA 联合治疗的神经保护策略

Carlini, Maria J; Espinoza-Derout, Jorge; Van Alstyne, Meaghan; Tisdale, Sarah; Workman, Eileen; Triplett, Marina K; Tattoli, Ivan; Yadav, Shubhi; Henderson, Christopher E; Watterson, D Martin; Pellizzoni, Livio

Optimized 5-HT(2b) inhibitors for neuropsychiatric syndromes with cognitive dysfunction

针对伴有认知功能障碍的神经精神综合征的优化型 5-HT(2b) 抑制剂

Roy, Saktimayee M; Acquarone, Erica; Argyrousi, Elentina K; Zhang, Hong; Staniszewski, Agnieszka; Inoue, Asuka; Ziarek, Joshua J; Arancio, Ottavio; Watterson, D Martin

Discovery of small molecule candidate therapeutics against neuroimmune targets in Alzheimer’s disease

发现针对阿尔茨海默病神经免疫靶点的小分子候选疗法

Islam, Rezwanul; Vrionis, Frank; Hanafy, Khalid A; Eldik, Linda Jo Van; Roy, Saktimayee M; Arancio, Ottavio; Watterson, D Martin

The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction

阿尔茨海默病中的5HT2b受体:患者脑内水平升高及拮抗剂可减轻淀粉样蛋白和tau蛋白诱导的功能障碍

Acquarone, Erica; Argyrousi, Elentina K; Arancio, Ottavio; Watterson, D Martin; Roy, Saktimayee M

Stasimon Contributes to the Loss of Sensory Synapses and Motor Neuron Death in a Mouse Model of Spinal Muscular Atrophy.

Stasimon 会导致脊髓性肌萎缩症小鼠模型中的感觉突触丢失和运动神经元死亡

Simon Christian M, Van Alstyne Meaghan, Lotti Francesco, Bianchetti Elena, Tisdale Sarah, Watterson D Martin, Mentis George Z, Pellizzoni Livio

A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction

一种选择性强、可穿透血脑屏障的p38αMAPK抑制剂,有望用于治疗神经系统和神经精神疾病,并能减轻神经炎症和认知功能障碍。

Roy, Saktimayee M; Minasov, George; Arancio, Ottavio; Chico, Laura W; Van Eldik, Linda J; Anderson, Wayne F; Pelletier, Jeffrey C; Watterson, D Martin

Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia

肌球蛋白轻链激酶(MLCK210)基因敲除可预防血管性认知障碍和痴呆小鼠模型中的脑微出血并减轻神经炎症

Braun, David J; Bachstetter, Adam D; Sudduth, Tiffany L; Wilcock, Donna M; Watterson, D Martin; Van Eldik, Linda J

111 Changes in proinflammatory cytokines and chemokines in beef steers chronically exposed to endophyte-infected tall fescue seed

111 长期暴露于内生真菌感染的高羊茅种子的肉牛体内促炎细胞因子和趋化因子的变化

Da Silva, Diane M; Woodham, Andrew W; Naylor, Paul H; Egan, James E; Berinstein, Neil L; Kast, W Martin; Eldik, Linda Jo Van; Roy, Saktimayee M; Arancio, Ottavio; Watterson, D Martin; Brown, Alecia R; Poole, Rebecca K; Jackson, McKenzie Lane; Poore, Matthew H; Pickworth, Carrie L; Poole, Daniel H

p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse

p38α MAPK信号通路驱动SERT Ala56小鼠出现药理学可逆的脑和胃肠道表型。

Robson, Matthew J; Quinlan, Meagan A; Margolis, Kara Gross; Gajewski-Kurdziel, Paula A; Veenstra-VanderWeele, Jeremy; Gershon, Michael D; Watterson, D Martin; Blakely, Randy D